EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,348.90
arrow_downward
-0.54%(-12.80) 1D
Nov 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹2,350.00
High
₹2,389.80
Low
₹2,326.60
Mkt. cap
445.11B
Avg. vol.
228.06K
Volume
104.51K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.31
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
Open
₹2,350.00
High
₹2,389.80
Low
₹2,326.60
Mkt. cap
445.11B
Avg. vol.
228.06K
Volume
104.51K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.31
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
News stories
From web sources and news partners
The Korea Times
·
1 hour ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
1 hour ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
2 hours ago
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
The Motley Fool
·
39 minutes ago
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com